First United Bank & Trust »

Iovance Biotherapeutics shares owned by First United Bank & Trust

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by First United Bank & Trust from 13F filings

Historical chart of First United Bank & Trust investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by First United Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by First United Bank & Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.4k 1.0k 9.39
2024-06-30 $8.0k 1.0k 8.02
2024-03-31 $15k 1.0k 14.82

More positions owned by First United Bank & Trust

Invesco QQQ Unit Series 1 Unit Ser 1 (QQQ)
Vanguard Value ETF Value Etf (VTV)
Vanguard Index FDS S&P 500 ETF S&p 500 Etf Shs (VOO)
Apple (AAPL)
Vanguard Growth ETF Growth Etf (VUG)
Microsoft Corporation (MSFT)
iShares Select Dividend ETF Select Divid Etf (DVY)
Erie Indty Co CL A Cl A (ERIE)
Invesco S&P 500 Equal Weight S&p500 Eql Wgt (RSP)
Flexshares Stoxx US ESG Impact Index Stox Us Esg Slct (ESG)
Invesco S&P 500 Garp ETF S&p 500 Garp Etf (SPGP)
Arista Networks (ANET)
Vanguard Index FDS McAp GR Idxvip Mcap Gr Idxvip (VOT)
Vanguard Index FDS McAp Vl Idxvip Mcap Vl Idxvip (VOE)
Vanguard Mid-Cap ETF Mid Cap Etf (VO)

View all positions for First United Bank & Trust

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics